CRISPR Startups Give Genome Editing Several New Twists
By Catherine Shaffer,
Genetic Engineering & Biotechnology News
| 08. 03. 2020
Base editors, exonucleases, and other refinements enable advances in pathogen recognition, antibacterial development, genetic medicine, xenotransplantation, and agriculture
Just seven years ago, the Broad Institute’s Feng Zhang, PhD, and Harvard geneticist George Church, PhD, separately demonstrated that in human cell cultures, genome editing could be performed using a CRISPR system. CRISPR, which stands for clustered regularly interspaced short palindromic repeats, first came to light as part of a naturally occurring defense system in bacteria. CRISPR DNA in bacteria includes repetitive elements and spacer elements, the latter of which encode RNA molecules that complex with a CRISPR-associated (Cas) nuclease and guide it to viral targets, that is, viruses that possess genetic material complementary to guide RNA.
After Zhang and Church showed that CRISPR-Cas9, one of the crude adaptive immune systems found in bacteria, had potential as a genomic engineering tool, many developers followed their lead. Early CRISPR startups—such as Editas Medicine, CRISPR Therapeutics, and Intellia Therapeutics—went public and have since prospered. And now a new crop of startups is showing that there’s still plenty of room for innovation.
Each of the new CRISPR startups features a unique twist on the original CRISPR formula. Examples of CRISPR twists include exotic...
Related Articles
By Fyodor Urnov, Time | 08.12.2024
After a lifetime in the field of epigenetics, and nearly 20 years after my colleagues and I coined the term “genome editing,” I will be the first to admit that describing the “epigenome”—a marvelous biological process that guides...
By Azeen Ghorayshi and Sarah Kliff, The New York Times | 08.12.2024
An emerging movement against in vitro fertilization is driving some doctors and patients in red states to move or destroy frozen embryos.
The embryo migration is most striking in Alabama, where the State Supreme Court ruled in February that embryos...
By Gemma Conroy, Nature | 06.27.2024
Image by Robina Weermeijer from Unsplash
A molecular-editing tool that’s small enough to be delivered to the brain shuts down the production of proteins that cause prion diseases, a rare but deadly group of neurodegenerative disorders.
The system — known...
By Staff, AP-NORC | 07.12.2024
Image by Dr. Jayesh Amin from Wikimedia Commons licensed under CC by-SA 3.0
Most adults support protecting access to in vitro fertilization, or IVF, a type of fertility treatment where eggs are combined with sperm outside the body in a...